Materials 2010, 3(1), 638-655; doi:10.3390/ma3010638

Current Strategies in Cardiovascular Biomaterial Functionalization

1,* email, 2email, 1email and 1email
Received: 11 November 2009; in revised form: 15 January 2010 / Accepted: 20 January 2010 / Published: 22 January 2010
(This article belongs to the Special Issue Biocompatibility of Materials)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Prevention of the coagulation cascade and platelet activation is the foremost demand for biomaterials in contact with blood. In this review we describe the underlying mechanisms of these processes and offer the current state of antithrombotic strategies. We give an overview of methods to prevent protein and platelet adhesion, as well as techniques to immobilize biochemically active molecules on biomaterial surfaces. Finally, recent strategies in biofunctionalization by endothelial cell seeding as well as their possible clinical applications are discussed.
Keywords: tissue engineering; cardiovascular; biomaterials; biofunctionalization
PDF Full-text Download PDF Full-Text [97 KB, uploaded 22 January 2010 10:21 CET]

Export to BibTeX |

MDPI and ACS Style

Schopka, S.; Schmid, T.; Schmid, C.; Lehle, K. Current Strategies in Cardiovascular Biomaterial Functionalization. Materials 2010, 3, 638-655.

AMA Style

Schopka S, Schmid T, Schmid C, Lehle K. Current Strategies in Cardiovascular Biomaterial Functionalization. Materials. 2010; 3(1):638-655.

Chicago/Turabian Style

Schopka, Simon; Schmid, Thomas; Schmid, Christof; Lehle, Karla. 2010. "Current Strategies in Cardiovascular Biomaterial Functionalization." Materials 3, no. 1: 638-655.

Materials EISSN 1996-1944 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert